REG - Arbuthnot Banking - Transaction in Own Shares

Arbuthnot BankingAnnouncement

31/03/2020 17:30

RNS Number : 3050I
  
Arbuthnot Banking Group PLC
  
31 March 2020
  
 

 
 
 
31 March 2020
 
 
Arbuthnot Banking Group PLC 
 
Transaction in own shares
 
Arbuthnot Banking Group PLC announces that on 31 March 2020 it acquired 7,730 Ordinary Non-Voting shares at a price of £11.00 per Ordinary Non-Voting share.
Following this purchase the total number of Ordinary Non-Voting shares held in treasury is 19,040 and the total number of Ordinary Non-Voting shares in issue (excluding shares held as treasury shares) is 133,581.  The Company also has 14,889,048 Ordinary shares in issue (excluding shares held as treasury shares).
The Directors of the Company accept responsibility for the contents of this announcement.
Enquiries:
 
Arbuthnot Banking Group                                                                               0207 012 2400
Sir Henry Angest, Chairman and Chief Executive
Andrew Salmon, Group Chief Operating Officer
James Cobb, Group Finance Director
 
Grant Thornton UK LLP (Nominated Adviser and                                           0207 383 5100
NEX Exchange Corporate Advisor)                                                       



Colin Aaronson / Samantha Harrison / Niall McDonald







 
Numis Securities Ltd (Joint Broker)                                                                  0207 260 1000
Stephen Westgate
 
Shore Capital Ltd (Joint Broker)                                                                      0207 408 4090
Hugh Morgan/ Daniel Bush
 
Maitland/AMO (Financial PR)                                                                          0207 379 5151
Neil Bennett / Sam Cartwright / Jonathan Cook                                                                                                             
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
POSKKDBBABKDNNN